Related Experiment Videos
Functional proteomic analysis of melanoma progression
Karine Bernard1, Elizabeth Litman, James L Fitzpatrick
1Department of Chemistry and Biochemistry, University of Colorado, Boulder, Colorado 80309, USA.
Cancer Research
|October 30, 2003
Summary
Hepatoma-derived growth factor (HDGF) and nucleophosmin B23 are key protein markers associated with melanoma progression. Their altered expression and modification, particularly HDGF
Area of Science:
- Proteomics and cancer biology
- Molecular mechanisms of melanoma development
Background:
- Melanoma progression involves changes in protein expression and post-translational modifications.
- Identifying reliable biomarkers is crucial for understanding and diagnosing melanoma.
Purpose of the Study:
- To identify novel protein markers associated with melanoma progression using functional proteomics.
- To investigate the differential expression and modification of candidate proteins in melanoma cell lines and human tissues.
Main Methods:
- Proteomic profiling of melanocyte and melanoma cell lines using 2D electrophoresis and mass spectrometry.
- Western blotting to validate protein expression and modifications.
- Immunohistochemical analysis of human melanoma and nevus tissue biopsies.
Main Results:
- Eight candidate protein markers were identified as differentially regulated in melanoma cells.
- Hepatoma-derived growth factor (HDGF) and nucleophosmin B23 showed strong correlation with melanoma.
- HDGF expression was elevated in melanomas and decreased in nevi with depth, suggesting altered dependence on epidermal interactions. Nucleophosmin B23 showed increased, likely phosphorylated, forms in melanoma.
Conclusions:
- HDGF and nucleophosmin B23 are promising biomarkers for melanoma.
- HDGF expression patterns suggest a loss of dependence on epidermal interactions during melanoma progression.
- Post-translational modifications, such as phosphorylation of nucleophosmin B23, are significant in melanoma development.